Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fujirebio Diagnostics Inc.

Division of Miraca Holdings Inc.
www.fujirebioamerica.com

Latest From Fujirebio Diagnostics Inc.

Washington Roundup, February 2013

The latest medical device regulatory and reimbursement news from Elsevier Business Intelligence’s “The Gray Sheet.”

Medical Device Legislation

As Big DX Companies Consolidate, What Are Smaller Companies To Do?

If large diagnostics companies are consolidating at a record pace these days, smaller companies are also struggling for ways to cope with the brutalities of the current market. Some are cutting back on projects or looking to eliminate altogether their involvement in diagnostics. Others are forging relations with other small companies, something they haven't done much of in the past.
Medical Device Business Strategies

Grading Diagnostics Start-Ups

While diagnostics start-ups have delivered good returns to private investors, they've performed miserably for the public, with a few significant exceptions. In this statistical review, we segment the industry, showing the trends that have won with investors (automation, drug-focused diagnostics) and those that have lost big (point-of-care testing).
Medical Device Leadership

A Slew of Diagnostics Financings

The past two months have seen a surge in diagnostic financings, driven partly by renewed enthusiasm for biotech stocks overall and a pent-up need for capital.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Therapeutic Areas
  • Alias(es)
  • Centocor Diagnostics Inc.
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Miraca Holdings Inc.
  • Senior Management
  • Paul Touhy, Pres. & CEO
    Olle Nilsson, PhD, VP, Bus. Dev.
    Grady Barnes, PhD, CSO
  • Contact Info
  • Fujirebio Diagnostics Inc.
    Phone: (610) 240-3800
    201 Great Valley Parkway
    Malvern, PA 19335-1307
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register